InterVenn Biosciences
PrivateLast Round
Series C
Aug 2, 2021
Total Funding Raised
$244.4M
Momentum
Top 10%
of companies Caplight tracks
Company Overview
InterVenn Biosciences is a biotechnology company that develops an AI-powered platform for glycoproteomic analysis to enhance early cancer detection and precision medicine.
Sector
Healthcare & Life Sciences
Verticals
Biotechnology, Precision Medicine, Medical AI, Drug Discovery
Business Model
B2B
Customer Profile
Services & Consulting, Data as a Service
AI Layer
Application
Keywords
Historical Pricing
Historical view of private secondary pricing and transaction trends.
InterVenn Biosciences Comps
Public and private peers based on sector, stage, and business model.
| Company | Status | Est. Valuation | Rev Multiple |
|---|---|---|---|
| OpenAI | Private | $86.0B | ~40x |
| Cohere | Private | $5.0B | -- |
| Competitor 1 | Public | $XX.XB | XXx |
| Competitor 2 | Public | $XX.XB | XXx |
InterVenn Biosciences Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Series C | Aug 2, 2021 | ||||
| Series B | Nov 16, 2020 | ||||
| Series A | Dec 12, 2018 |
Key People
Founding team and executive leadership
InterVenn Biosciences Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| Xeraya Capital | Series B, Series C |
| Ojjeh Family | Series B |
| Highside Capital Management | Series C |
| Prado SV | Series A |
| SoftBank Group | Series C |
| Genoa Ventures | Series B, Series C, Series A |
| Irving Investors | Series C |
Market signals
Structured signals derived from secondary market and firmographic data.
- May 25, 2026
Grew 21% QoQ, from 39 to 47 employees.
- Mar 18, 2025
Andrew Quong appointed as the new Chief Executive Officer.
InterVenn Biosciences Filings
SEC and related filings with document metadata.
| Typed | Date | Amount Offered | Amount Sold | Filling | Pages | Download |
|---|---|---|---|---|---|---|
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Frequently Asked Questions
Common questions about InterVenn Biosciences's valuation, stock price, and market status.